Doctor profile · Federal record
Dr. Uchenna Onwuegbusi, MD
Student in an Organized Health Care Education/Training Program (CMS: Family Practice) · Los Angeles, CA
- NPI 1831710870
- Accepts Medicare
- 7 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1731 E 120Th St
Los Angeles, CA 900593051
(323) 563-4812 - Mailing address
-
6200 93Rd Pl
Lanham, MD 207062729
Credentials & registration
- NPI registered
- April 2020 — 6 yrs on file
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 390200000X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831710870. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
265
Distinct HCPCS
5
Medicare allowed
$26,113
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 138 | 49 | $79 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 78 | 39 | $119 | |
99239 |
Hospital discharge day management, more than 30 minutes | 19 | 19 | $115 | |
99238 |
Hospital discharge day management, 30 minutes or less | 16 | 16 | $81 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 14 | 14 | $173 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 77. This provider delivers 3.4× the peer median.Open Payments
Industry payments received
All-time total
$110
Transactions
4
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $43.84 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23.43 | |
| Merck Sharp & Dohme LLC | 1 | $22.68 | |
| Janssen Pharmaceuticals, Inc | 1 | $19.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
129
Patients
16
Total drug cost
$3,416
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 32 | 16 | $935 |
| Gabapentin | Generic | 20 | 0 | $445 |
| Amlodipine Besylate | Generic | 17 | 0 | $570 |
| Hydrochlorothiazide | Generic | 14 | 0 | $107 |
| Losartan Potassium | Generic | 13 | 0 | $215 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 11 | 0 | $505 |
| Diclofenac Sodium | Generic | 11 | 0 | $344 |
| Metoprolol Succinate | Generic | 11 | 0 | $297 |
Hospital affiliations
Frequently asked questions
What is Dr. Uchenna Onwuegbusi's medical specialty?
Dr. Uchenna Onwuegbusi practices Student in an Organized Health Care Education/Training Program in Los Angeles, CA.
Where does Dr. Uchenna Onwuegbusi practice?
Dr. Uchenna Onwuegbusi practices at 1731 E 120Th St, Los Angeles, CA 900593051. Office phone: 3235634812.
What is Dr. Uchenna Onwuegbusi's NPI?
Dr. Uchenna Onwuegbusi's National Provider Identifier (NPI) is 1831710870, issued by NPPES.
Does Dr. Uchenna Onwuegbusi accept Medicare assignment?
Yes. Dr. Uchenna Onwuegbusi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Uchenna Onwuegbusi commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Hospital discharge day management (HCPCS 99239). Source: CMS Medicare Physician & Other Practitioners file.